Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit
Novavax Surging On $60M Funding For Covid-19 Vaccine Candidate
Inovio Suing Suppliers Over Covid-19 Vaccine Production
Too Much Uncertainty Keeps This 5-Star Analyst Watching Amarin Stock From the Sidelines
Daily Crunch: Snapchat says it won’t promote Trump
Intravacc Partners to Develop Intranasal COVID-19 Vaccine
3 “Strong Buy” Penny Stocks That Could See Outsized Returns
COVID-19, smell and taste – how is COVID-19 different from other respiratory diseases?
Coronavirus pharma news roundup – 04/06/20
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
Estimating a US price tag of $5K per course, remdesivir is set to make billions for Gilead, says key analyst
LabCorp Launches Website to Connect Patients with COVID-19 Clinical Trials
Moderna (MRNA) Given 75% Probability to Develop COVID-19 Vaccine
Quest Sees Q2 EPS In Range Of Breakeven To Profitable On Testing Volume Recovery
BMS launches COVID-19 delayed MS drug Zeposia in US
Philips Gets FDA Emergency Use Nod For Monitors, Displays During Covid-19 Pandemic
This Analyst Thinks Menlo (MNLO) Stock Is Poised for Growth
HCQ Misinformation Can Be Deadly: Let Patients Decide
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Aveo’s Tivozanib Gets FDA Nod For New Drug Application To Treat Kidney Cancer
Gilead Sinks 3% On New Remdesivir Data; Analysts Stay Sidelined
Solubilizer Captisol enables body to absorb authorized COVID-19 drug therapy
Quest’s Covid-19 Self-Collection Test Kit Gets FDA Nod For Emergency Use
Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients
FDA approval for Brilinta, EU recommendation for Lynparza
3 "Strong Buy" Biotech Stocks Under $5 With Major Catalysts Approaching
3 'Strong Buy' Biotech Stocks Under $5 That Could Go Boom
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
Eli Lilly’s Taltz Injection Gets FDA Nod For Inflammatory Spine Arthritis Treatment